Downstream Manufacturing Solutions

  1. Synthesis Columns: THESYS® SCS Column And THESYS® ACS Column 12/23/2025

    Explore how advanced synthesis columns with specialized flow distribution and ergonomic design optimize reagent dispersal and simplify maintenance to support rigorous cGMP manufacturing requirements.

  2. VANTIJ® Virus Filtration Solutions 12/22/2025

    Learn about automated systems that bridge the gap between filtration and buffer recovery, enhancing reproducibility and efficiency across clinical and commercial manufacturing scales.

  3. VANTIJ® Single-Use Virus Filtration Controller 12/22/2025

    Automating critical filtration steps significantly reduces cross-contamination risks and operational costs. This single-use approach ensures process repeatability and eliminates cleaning downtime.

  4. Aseptic Manufacturing: Fill/Finish For Vials, Syringes, Cartridges 12/18/2025

    Sterile fill/finish requires isolator technology and regulatory compliance. From clinical development to commercial scale, technical expertise ensures the integrity of liquid and lyophilized injectables.

  5. Contamination Control And Risk Assessment Advisory Services 12/15/2025

    PMS is here to help with all your cleanroom contamination needs.

  6. Particle Loss Studies 12/15/2025

    Ensure Compliance. Safeguard Sterility. Drive Manufacturing Excellence.

  7. Biopharmaceutical Chromatography Solutions 12/11/2025

    Achieve maximum analyte recovery with bioinert column hardware. Advanced particle platforms and diverse chemistries provide superior resolution and robust performance for complex bioseparations.

  8. Blood Infusion Syringe Filter For Microaggregate Removal 12/10/2025

    The Neonatal Syringe Set with 40μm Filter is designed for the removal of microaggregates and particulate debris from whole blood and red blood cells (RBC) during infusion.

  9. Syringe System For Pediatric Blood And Plasma Transfusion 12/8/2025

    The Neonatal Syringe Set with 150μm is designed to prepare and deliver small aliquots of filtered whole blood, red blood cells, platelets, and fresh frozen plasma for neonatal/pediatric transfusion.

  10. Powering Production Of Viral Vector-Based Therapies 11/14/2025

    Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.